Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - OPERATING INCOME
Operating Income FOLD - Amicus Therapeutics, Inc.
-73.5 M
LAST VALUE
39.37%
2 YEAR CAGR
25.89%
5 YEAR CAGR
-1.36%
10 YEAR CAGR